Latest News for Arem Pacific Stock (OTC:ARPC)

Arem Pacific Corporation is engaged in providing wellness services. The company operates in one industry and one geographical segment, those being Oriental holistic health services and Australia. The Wellness center provides services including Acupressure/Reflexology which is acupuncture without needles, Massage Therapy involving application of soft-tissue manipulation techniques to the body and Cupping involving warming of glass cups through a flammable substance. It also offers Neck, shoulder, back, legs, full body massages and deep tissue and hot oil massage. It derives revenues through the provision of therapeutic health services from its Oriental holistic health centres.

Arem Pacific Corp

Vertiv Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.36 by 19.44 percent. This is a 79.17 percent increase over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $1.64 billion which beat the analyst consensus estimate of $1.62 billion by 1.17 percent. This is a 7.75 percent increase over sales of $1.52 billion the same period last year.

Earnings

News

Vertiv Hldgs Q1 Adj. EPS $0.43 Beats $0.36 Estimate, Sales $1.64B Beat $1.62B Estimate

Amazon.com Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has launched a new grocery delivery subscription benefit&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38373619/amazon-introduces-low-cost-grocery-delivery-subscription-for-prime-members-and-customers-using-ebt" rel="noreferrer noopener">available&nbsp;to Prime members and customers using EBT.</a>
The facility will be available in more than 3,500 cities and towns across the U.S. At $9.99 per month for Prime members, the subscription provides unlimited grocery delivery on orders over $35 from Amazon Fresh, Whole Foods Market along with local grocery and specialty retailers on Amazon.com.
Customers who hold a registered EBT card avail grocery subscription benefits without a Prime membership for $4.99 per month. The Subscription includes one-hour delivery windows at no extra cost, unlimited 30-minute pickup on orders of any size.
&#8220;This new grocery subscription benefit provides even more value and savings on delivery fees for customers who regularly order groceries from Amazon Fresh, Whole Foods Market, and the variety of local grocery and specialty retailers on Amazon.com,&#8221; said Tony Hoggett, senior vice president of worldwide grocery stores at Amazon.
The service aims to streamline grocery shopping, offering one-hour delivery windows where available and priority access to Recurring Reservations for weekly orders.
Following successful pilots in select cities, Amazon&#8217;s grocery subscription garnered high satisfaction rates among users. Over 85% of respondents expressed extreme or very high satisfaction with the free delivery benefit, citing savings on fees and enhanced convenience as key factors for continued subscription.
Amazon stock gained 69% in the last 12 months. Investors can gain exposure to the stock via&nbsp;SPDR Select Sector Fund&nbsp;–&nbsp;Consumer Discretionary&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) and&nbsp;Vanguard Consumer Discretion ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VCR#NYSE">VCR</a>).
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38376999/amazon-ends-drone-deliveries-in-lockeford-sets-eye-on-new-arizona-site-for-expansion" rel="noreferrer noopener">Amazon Ends Drone Deliveries in Lockeford, Sets Eye on New Arizona Site for Expansion</a>
Price Action: AMZN shares closed higher by 1.30% at $179.544 on Tuesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Equities

General

AMZN

Select Sector SPDR-Consumer Discretionary

Enhanced Convenience: Amazon Launches New Affordable Grocery Delivery Subscription

Needham analyst Chris Pierce reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Hold.

Reiteration

Analyst Ratings

TSLA

Needham Reiterates Hold on Tesla

Needham analyst Mayank Tandon maintains CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) with a Buy and raises the price target from $90 to $107.

Price Target

CSGP

Needham Maintains Buy on CoStar Gr, Raises Price Target to $107

Needham analyst Quinn Bolton reiterates Vicor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) with a Hold.

VICR

Needham Reiterates Hold on Vicor

B. Riley Securities analyst Jeff Lick upgrades Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) from Sell to Neutral and lowers the price target from $12 to $7.

Upgrades

PLCE

B. Riley Securities Upgrades Children's Place to Neutral, Lowers Price Target to $7

&nbsp;Immutep Limited ((ASX: IMM, NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) (&ldquo;Immutep&rdquo; or &ldquo;the Company&rdquo;), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces preliminary topline results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) &nbsp;Phase &nbsp;IIb &nbsp;trial &nbsp;evaluating &nbsp;eftilagimod &nbsp;alpha &nbsp;(efti) in combination with MSD&rsquo;s anti-PD-1 &nbsp;therapy KEYTRUDA&reg; &nbsp;(pembrolizumab) &nbsp;as &nbsp;first-line treatment of &nbsp;recurrent/metastatic &nbsp;head &nbsp;and &nbsp;neck &nbsp;squamous &nbsp;cell carcinoma patients (1L HNSCC) with negative PD-L1 expression.

IMMP

Immutep Announced Tuesday, Data  From Efti In  Combination  With Keytruda In  First  Line Head  And  Neck  Squamous  Cell  Carcinoma Patients Who Do Not Express PD-L1 Shows A Preliminary 26.9% Response Rate, The Primary Endpoint Of The Study

Pivotal Research analyst Jeffrey Wlodarczak upgrades Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) from Hold to Buy and lowers the price target from $5.05 to $4.9.

SIRI

Pivotal Research Upgrades Sirius XM Holdings to Buy, Lowers Price Target to $4.9

<a href="https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-positive-efficacy-and-safety-data-novel-treatment-babies" title="https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-positive-efficacy-and-safety-data-novel-treatment-babies">https://www.novartis.com/news/media-releases/novartis-and-medicines-malaria-venture-announce-positive-efficacy-and-safety-data-novel-treatment-babies</a>

Biotech

Large Cap

Health Care

Novartis And Medicines For Malaria Venture Announced Data From Phase 2/3 CALINA Study, Demonstrating That Formulated Coartem Developed For Babies Weighing Less Than 5Kg With Malaria Has The Required Pharmacokinetic Profile, Good Efficacy, And Safety

Elon Musk has escalated his conflict with the Australian government, advocating for the incarceration of a senator and voicing criticism of Australia&#8217;s gun laws. This follows a court directive to remove a violent video from his social media platform, X.
What Happened: On Tuesday, an X user posted a clip of Australian Sen. Jacqui Lambie who deleted her X account and encouraged other politicians to follow suit. Lambie criticized Musk for his lack of social conscience and suggested he should be jailed.
"…quite frankly, the power that that man has because of that platform that he's on, it's got to stop. It has absolutely got to stop. But leaving that out for our kids to see, for people that were family and friends out there and just letting that run on there, once again, that bloke has no conscience. He's an absolute friggin disgrace, and there's nothing else to say about Elon Musk," Lambie said. 
Musk responded to the post, saying, &#8220;Absolutely. She is an enemy of the people of Australia.&#8221;
Musk&#8217;s disagreement with Australian authorities heightened after a federal court demanded his social media platform, X, to temporarily stop displaying a video showing a knife assault on an Assyrian bishop, This order led Musk to accuse Australia&#8217;s leaders of internet censorship.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Absolutely. She is an enemy of the people of Australia.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1782823597381414933?ref_src=twsrc%5Etfw">April 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/04/38357333/elon-musk-reacts-to-tucker-carlson-saying-theres-ton-of-evidence-that-aliens-live-among-us-with-6000?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Reacts To Tucker Carlson Saying There&#8217;s &#8216;Ton Of Evidence&#8217; That Aliens Live Among Us: &#8216;With 6000 Satellites Orbiting Earth, I Think I Would Know&#8217;</a>
Why It Matters: This incident follows a <a href="https://www.benzinga.com/government/23/10/35257873/elon-musks-x-faces-386k-penalty-in-australia-for-dodging-child-abuse-probe">penalty of $386,000</a> that was imposed on X by the Australian regulator last year for inadequate compliance with a child abuse prevention investigation.
Musk extended his criticism to Australia&#8217;s 1996 gun buy-back and registration scheme, endorsing a post that alleged the scheme was designed to prevent resistance against its &#8220;fascist government&#8221;.
Australia&#8217;s Home Affairs Minister <a href="https://www.benzinga.com/news/24/04/38368734/elon-musk-hits-back-at-australias-leader-amid-row-over-removal-of-violent-video-from-x-does-the-pm-t">Clare O&#8217;Neill accused social media companies</a> of inciting &#8220;civil division, social unrest&#8221; and criticized Musk for legally defending the right to display alleged terrorist content on his platform. 
A hearing to decide the permanence of the takedown order is scheduled for May 10.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38348301/bitcoin-halving-elon-musks-dogecoin-tweet-solanas-rise-and-more-this-week-in-cryptocurrenc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin Halving, Elon Musk&#8217;s Dogecoin Tweet, Solana&#8217;s Rise And More: This Week In Cryptocurrency</a>
Photo courtesy: Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Social Media

Global

Tech

'Enemy Of People:' Elon Musk Slams Australian Senator After She Calls Tesla CEO 'Absolute Friggin Disgrace'

Pivotal Research analyst Jeffrey Wlodarczak maintains Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Buy and raises the price target from $390 to $400.

SPOT

Pivotal Research Maintains Buy on Spotify Technology, Raises Price Target to $400

Needham analyst Joshua Reilly reiterates Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) with a Buy and maintains $400 price target.

AXON

Needham Reiterates Buy on Axon Enterprise, Maintains $400 Price Target

Piper Sandler analyst Brad Milsaps downgrades Independent Bank Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) from Neutral to Underweight and lowers the price target from $48 to $38.

Downgrades

IBTX

Piper Sandler Downgrades Independent Bank Gr to Underweight, Lowers Price Target to $38

Needham analyst Ryan Koontz maintains Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Buy and lowers the price target from $50 to $45.

CALX

Needham Maintains Buy on Calix, Lowers Price Target to $45

Piper Sandler analyst Brian Mullan initiates coverage on Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) with a Neutral rating and announces Price Target of $114.

Initiation

KRUS

Piper Sandler Initiates Coverage On Kura Sushi USA with Neutral Rating, Announces Price Target of $114

Piper Sandler analyst Stephen Scouten upgrades SmartFinancial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBK#NYSE">SMBK</a>) from Neutral to Overweight and raises the price target from $25 to $26.

SMBK

Piper Sandler Upgrades SmartFinancial to Overweight, Raises Price Target to $26

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAWN#NASDAQ">DAWN</a>) with a Buy and raises the price target from $30 to $33.

DAWN

Needham Maintains Buy on Day One Biopharmaceutical, Raises Price Target to $33

Mizuho analyst James Lee upgrades Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) from Neutral to Buy and raises the price target from $150 to $200.

ABNB

Mizuho Upgrades Airbnb to Buy, Raises Price Target to $200

Outlook&nbsp;for the&nbsp;Fourth Quarter&nbsp;of the Fiscal Year 2024
New Oriental expects total net revenues in the&nbsp;fourth quarter&nbsp;of the fiscal year 2024 (March 1, 2024&nbsp;to&nbsp;May 31, 2024) to be in the range of&nbsp;US$1,101.5 million&nbsp;to&nbsp;US$1,127.3 million, representing year over year increase in the range of&nbsp;28%&nbsp;to&nbsp;31%.
The projected increase of revenue in our functional currency Renminbi is expected to be in the range of&nbsp;34%&nbsp;to&nbsp;37%&nbsp;for the&nbsp;fourth quarter&nbsp;of the fiscal year 2024.

Guidance

New Oriental Education & Technology Group

New Oriental Education Expects Q4 Revenue of $1.102B-$1.127B Vs $1.099B Est

New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) reported quarterly earnings of $0.63 per share which missed the analyst consensus estimate of $0.79 by 20.25 percent. This is a 12.5 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $1.207 billion which beat the analyst consensus estimate of $1.105 billion by 9.30 percent. This is a 60.09 percent increase over sales of $754.153 million the same period last year.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Arem Pacific Stock (OTC:ARPC)

Friday, September 06, 2019

Wednesday, August 07, 2019

Wednesday, July 31, 2019